David Hung

Anderson is a veteran of the hospitality industry with more than 30 years of real estate and operations experience

Pharma

JPM need-to-know: Lilly, Novartis, Dynavax, Aimmune and more

The 2018 J.P. Morgan Healthcare Conference is receding in biopharma's rearview mirror, but industry watchers have only begun digesting the commentary.

Tracy Staton Jan 8, 2018 12:38pm

Kite chief up for $600M-plus payday in Gilead buyout

Aug 31, 2017 11:55am

Medivation CEO set for $350M payoff when Pfizer closes its $14B deal

Aug 31, 2016 8:51am